Skip to main content

Table 2 Comparison to standard biopsy for detection performance

From: A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy

 

csPCa, n (%)

Accuracy (%)

PPV (%)

NPV (%)

P*

STB

162 (83.5)

    

TB

151 (77.8)

94.3

100

74.4

< 0.01

TrSB

161 (83.0)

99.5

100

97.0

> 0.999

 

ciPCa, n (%)

    

STB

32 (16.5)

    

TB

20 (10.3)

91.8

83.3

92.9

0.077

TrSB

28 (14.4)

97.4

96.6

97.6

0.375

  1. csPCa indicates clinically significant prostate cancer, ciPCa indicates clinically insignificant prostate cancer, PPV indicates positive predictive value, NPV indicates negative predictive value, TB indicates targeted biopsy, TrSB indicates targeted and regional systematic biopsy
  2. *Comparison to standard biopsy (SB + TB) for detection performance, McNemar test
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us